Quick Dispatch:
Your glutathione lung cancer Anti-human lung cancer activities and survey of glutathione reductase and glutathione S transferase inhibition properties with molecular modeling studies of 2′-hydroxy-5′-methyl-3′-nitroacetophenone: a pre-clinical trial study orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glutathione lung cancer Anti-human lung cancer activities and survey of glutathione reductase and glutathione S transferase inhibition properties with molecular modeling studies of 2′-hydroxy-5′-methyl-3′-nitroacetophenone: a pre-clinical trial study ships.
Need Help?
Questions about glutathione lung cancer Anti-human lung cancer activities and survey of glutathione reductase and glutathione S transferase inhibition properties with molecular modeling studies of 2′-hydroxy-5′-methyl-3′-nitroacetophenone: a pre-clinical trial study, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glutathione lung cancer Anti-human lung cancer activities and survey of glutathione reductase and glutathione S transferase inhibition properties with molecular modeling studies of 2′-hydroxy-5′-methyl-3′-nitroacetophenone: a pre-clinical trial study in your area.
NRF2 supports non-small cell lung cancer growth independently of CBP/p300-enhanced glutathione synthesis | EMBO Reports
22.51
A study from the Birsoy lab showed that the antioxidant glutathione, when operating inside mitochondria, is a key factor enabling tumors to spread from the breast to the lung. #RockefellerScience #YearInReview
20.90
Role of Glutathione in Cancer: From Mechanisms to Therapies
29.63
Decreased glutathione biosynthesis contributes to EGFR T790M-driven erlotinib resistance in non-small cell lung cancer
22.81
Glutathione Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy
26.88
A cisplatin-based platinum(IV) prodrug containing a glutathione s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer
23.61
Illustration of glutathione-responsive paclitaxel dimeric nanoparticles...
28.76
